首页 › 股票 › ELOX

ELOX — ELOXX PHARMACEUTICALS INC

申报持仓市值$42.49M
持有基金数(最新)42
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)22
机构持仓市值$34.70M · 2.50M 股
新建/增持/减仓/清仓22 / 0 / 0 / 0 · 更新于 2026-11-14
前五大/前十大集中度80.0% / 99.9%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 22 家机构在其最新 13F 申报中持有 ELOX(ELOXX PHARMACEUTICALS INC),合计申报市值 $34.70M,对应 2.50M 股。持仓集中度较高:前五大持有人占申报市值的 80.0%,前十大的集中度为 99.9%。

与上一季度相比,22 家新建仓位。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

ELOXX PHARMACEUTICALS INC(ELOX)的主要机构持有人包括 Siren, L.L.C.、Aberdeen Group plc、Nantahala Capital Management, LLC,按 13F 申报市值在本页 42 家持有人中排名居前。

ELOX 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 15 1.90M $29.09M +11.3%
Q2 2026 22 2.50M $34.70M —
Q2 2024 1 62 $43 +0.0%
Q1 2024 1 62 $62 —
Q4 2023 4 91.02K $108.99K +0.0%
Q3 2023 17 512.01K $2.46M -1.3%
Q2 2023 5 42.19K $164.13K +0.0%
Q1 2023 7 43.01K $107.96K -32.7%

表内 8 个季度中,机构持股合计增加 4317%(Q1 2023 → Q3 2026);单季变动最大的是 Q1 2023(-32.7%)。

前 25 大机构持仓人(Q3 2026) — 15 家基金

基金股数金额组合权重变化
Siren, L.L.C. 400.00K $6.12M 0.14% 持有
Aberdeen Group plc 400.00K $6.12M 0.01% 持有
Nantahala Capital Management, LLC 400.00K $6.12M 0.28% 持有
Stonepine Capital Management, LLC 历史持仓 381.98K $5.85M 4.49% 减持
Morgan Stanley 202.63K $3.10M 0.00% 增持
VANGUARD CAPITAL MANAGEMENT LLC 78.68K $1.20M 0.00% 持有
Geode Capital Management 19.95K $305.37K 0.00% 新进
VANGUARD FIDUCIARY TRUST CO 13.67K $209.27K 0.00% 增持
UBS Group AG 2.03K $31.02K 0.00% 增持
Vanguard Global Advisers, LLC 718 $10.99K 0.00% 持有
Pioneer Family Office, LLC 96 $1.47K 0.00% 持有
Altshuler Shaham Ltd 25 $383 0.00% 持有
Towne Trust Company, N.A 5 $77 0.00% 持有
Activest Wealth Management 4 $61 0.00% 持有
SBI Securities Co., Ltd. 2 $31 0.00% 持有

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 22 家基金

基金股数金额组合权重变化
Aberdeen Group plc 400.00K $5.55M 0.01% 新进
EcoR1 Capital, LLC 历史持仓 400.00K $5.55M 0.28% 新进
Nantahala Capital Management, LLC 400.00K $5.55M 0.22% 新进
Samsara BioCapital, LLC 历史持仓 400.00K $5.55M 0.46% 新进
Siren, L.L.C. 400.00K $5.55M 0.11% 新进
Stonepine Capital Management, LLC 历史持仓 397.16K $5.51M 3.64% 新进
VANGUARD CAPITAL MANAGEMENT LLC 78.68K $1.09M 0.00% 新进
VANGUARD FIDUCIARY TRUST CO 10.60K $147.16K 0.00% 新进
SEVEN GRAND MANAGERS, LLC 10.00K $138.80K 0.01% 新进
Morgan Stanley 1.54K $21.43K 0.00% 新进
Vanguard Global Advisers, LLC 718 $9.97K 0.00% 新进
UBS Group AG 637 $8.84K 0.00% 新进
Wells Fargo & Co 126 $1.75K 0.00% 新进
Pioneer Family Office, LLC 96 $1.33K 0.00% 新进
ROYAL BANK OF CANADA 98 $1.00K 0.00% 新进
Altshuler Shaham Ltd 25 $347 0.00% 新进
BARCLAYS PLC 12 $167 0.00% 新进
Towne Trust Company, N.A 5 $69 0.00% 新进
Activest Wealth Management 4 $56 0.00% 新进
Citigroup Inc 4 $56 0.00% 新进
SBI Securities Co., Ltd. 2 $28 0.00% 新进
Point Nemo Capital, LLC 1 $14 0.00% 新进

Q2 2024 — 1 家基金

基金股数金额组合权重变化
Towne Trust Company, N.A 62 $43 0.00% 持有

Q1 2024 — 1 家基金

基金股数金额组合权重变化
Towne Trust Company, N.A 62 $62 0.00% 新进

Q4 2023 — 4 家基金

基金股数金额组合权重变化
MENORA MIVTACHIM HOLDINGS LTD. 52.35K $62.83K 0.00% 持有
Altshuler Shaham Ltd 25.12K $30.15K 0.00% 持有
Clal Insurance Enterprises Holdings Ltd 13.53K $16.00K 0.00% 持有
MEEDER ASSET MANAGEMENT INC 15 $18 0.00% 持有

Q3 2023 — 17 家基金

基金股数金额组合权重变化
ARMISTICE CAPITAL, LLC 275.00K $1.32M 0.02% 新进
SILVERARC CAPITAL MANAGEMENT, LLC 54.08K $260.10K 0.10% 新进
MENORA MIVTACHIM HOLDINGS LTD. 52.35K $251.83K 0.00% 新进
AMERICAN FINANCIAL GROUP INC 37.00K $178.00K 0.07% 新进
Altshuler Shaham Ltd 25.12K $120.84K 0.01% 新进
Vanguard Group 20.79K $99.98K 0.00% 持有
Geode Capital Management 19.59K $93.26K 0.00% 减持
Clal Insurance Enterprises Holdings Ltd 13.53K $65.00K 0.00% 新进
Atom Investors LP 10.64K $51.17K 0.01% 新进
Tower Research Capital LLC (TRC) 1.83K $8.80K 0.00% 新进
Wells Fargo & Co 1.17K $5.64K 0.00% 持有
ROYAL BANK OF CANADA 526 $3.00K 0.00% 新进
UBS Group AG 291 $1.40K 0.00% 新进
Morgan Stanley 79 $380 0.00% 持有
MEEDER ASSET MANAGEMENT INC 15 $72 0.00% 新进
GROUP ONE TRADING LLC 4 $19 0.00% 新进
JPMorgan Chase & Co 1 $5 0.00% 持有

查看全部 42 家持有基金 →

新建仓(Q2 2026)

完全清仓(较上季)

本季度没有被追踪基金完全清仓。

基金持仓历史 — 各季度股数(前 20 只基金)

基金Q3 2026Q2 2026Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Siren, L.L.C. 400.00K 400.00K — — — — — — — — — — —
Aberdeen Group plc 400.00K 400.00K — — — — — — — — — — —
Nantahala Capital Management, LLC 400.00K 400.00K — — — — — — — — — — —
Stonepine Capital Management, LLC 381.98K 397.16K — — — — — — — — — — —
Morgan Stanley 202.63K 1.54K — — — 79 79 79 80 3.18K 3.18K 5.63K 3.69K
VANGUARD CAPITAL MANAGEMENT LLC 78.68K 78.68K — — — — — — — — — — —
Geode Capital Management 19.95K — — — — 19.59K 20.26K 20.24K 20.20K 807.68K 802.41K 800.33K 798.06K
VANGUARD FIDUCIARY TRUST CO 13.67K 10.60K — — — — — — — — — — —
UBS Group AG 2.03K 637 — — — 291 — 469 123 — — 21.85K —
Vanguard Global Advisers, LLC 718 718 — — — — — — — — — — —
Pioneer Family Office, LLC 96 96 — — — — — — — — — — —
Altshuler Shaham Ltd 25 25 — — 25.12K 25.12K — — — — — — —
Towne Trust Company, N.A 5 5 62 62 — — — — — — — — —
Activest Wealth Management 4 4 — — — — — — — — — — —
SBI Securities Co., Ltd. 2 2 — — — — — — — — — — —
EcoR1 Capital, LLC — 400.00K — — — — — — — — — — —
Samsara BioCapital, LLC — 400.00K — — — — — — — — — — —
ARMISTICE CAPITAL, LLC — — — — — 275.00K — — — — — — —
SILVERARC CAPITAL MANAGEMENT, LLC — — — — — 54.08K — — — — — — —
MENORA MIVTACHIM HOLDINGS LTD. — — — — 52.35K 52.35K — — — — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold ELOX?

As of 2026-Q2, 22 institutional funds reported holding ELOX (ELOXX PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $34.70M.

How many shares of ELOX do institutions own?

13F filers reported 2.50M shares of ELOX, worth $34.70M in aggregate at the end of 2026-Q2.

Is institutional ownership of ELOX rising or falling?

No prior-quarter baseline is available for a directional read.

Who are the top institutional holders of ELOX?

The largest 13F holders are Siren, L.L.C., Aberdeen Group plc, Nantahala Capital Management, LLC, Stonepine Capital Management, LLC, EcoR1 Capital, LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of ELOXX PHARMACEUTICALS INC?

The major shareholders of ELOXX PHARMACEUTICALS INC (ELOX) by reported 13F value are Siren, L.L.C., Aberdeen Group plc, Nantahala Capital Management, LLC, Stonepine Capital Management, LLC, EcoR1 Capital, LLC, among 42 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 ELOX」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/ELOX/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →